It’s official: Pfizer’s New York headquarters will move to Hudson Yards and its slick new skyscraper, The Spiral. Left behind will be the 42nd Street building Pfizer has called home since 1961. More: Get ready, Pfizer HQ staffers: You’re moving
read moreResearchers led by the University of North Carolina scoured the database where pharma companies disclose payments they make to physicians and discovered that oncologists who treat metastatic kidney cancer or chronic myeloid leukemia were more likely to prescribe drugs made
read morePhilippine health authorities are digging into a growing list of suspected Dengvaxia deaths, while families have filed four new complaints calling for criminal charges against officials with the government, Sanofi and distributor Zuellig. More: Sanofi executives face more requests for
read moreManufacturing problems have created a shortage of Mylan’s EpiPens in Britain, forcing the company to ration the lifesaving injection devices. More: Manufacturing issues stoke fears of EpiPen shortage in Britain Source: fierce
read morePfizer is feeling sales pressure on its megablockbuster pneumococcal vaccine, Prevnar 13, but behind that big-selling shot are several pipeline candidates it is counting on to propel future vaccines growth. More: Don't sweat Prevnar's problems, Pfizer R&D chief says. New vaccines are on their
read moreAstraZeneca has bought rights to an experimental antisense therapy from Ionis Pharmaceuticals, in a deal that could be worth more than $300 million More: AZ buys Ionis’ NASH candidate Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals